Our preliminary hypothesis was that genetic variants of dopamine receptors may have functional consequences on the modulation of PRL secretion and may play an important role in the development of hyperprolactinemia, but the results of the study indicate that there is no association in the group of patients. The gene discussed is PRL; the disease is hyperprolactinemia.